Paper Review Records
All Paper Review Records
16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Ocular hyperemia with netarsudil/latanoprost fixed combination in glaucoma: an exploratory association analysis of tolerability outcomes by prior topical therapy and baseline ocular hyperemia
Gábor HollóShow moreShow less
1. Tutkimusz Ltd; 2. Prima Medica Health CentersShow moreShow less
A look into adverse renal effects of proton pump inhibitors
Marta Fernandez-Arquillue; Samuel J Martínez Domínguez; Ángel Lanas ArbeloaShow moreShow less
1. University of Zaragoza; 2. Hospital Clínico Universitario Lozano Blesa; 3. IIS Aragón (Instituto de Investigación Sanitaria Aragón); 4. Instituto de Salud Carlos IIIShow moreShow less
Long-term safety of treatment of hemophilia A: a comprehensive review
Johnny MahlanguShow moreShow less
1. University of the WitwatersrandShow moreShow less
Tolerance of methotrexate co-administered with pegloticase in patients with uncontrolled gout: overview of the findings from the mirror RCT
Vinicius Domingues; Abdul Abdellatif; Alexis Woods; Quinnie Yang; Michael E. Weinblatt; Junzhi Ji; Brad Marder; Brian LaMoreauxShow moreShow less
1. Florida State University; 2. Nephrology Division; 3. Amgen Inc; 4. Brigham and Women’s HospitalShow moreShow less
A safety review of JAK inhibitors for managing alopecia areata
Kanchalit Thanomkitti; Sofia Spagnolini; Antonella TostiShow moreShow less
1. Mahidol University; 2. University of Parma; 3. University of Miami Miller School of MedicineShow moreShow less
Psychedelics in psychiatry: comparative effectiveness, implementation, commercialization and safety lessons learned from intranasal esketamine
Roger S. McIntyreShow moreShow less
1. University of TorontoShow moreShow less
FAQ
How long does Expert Opinion On Drug Safety take to review a manuscript?
As of 2026-11-19, CrushSCI has 16 complete review records for Expert Opinion On Drug Safety. The fastest paper went from submission to acceptance in 35 days (Ocular hyperemia with netarsudil/latanoprost fixed combination in glaucoma: an exploratory association analysis of tolerability outcomes by prior topical therapy and baseline ocular hyperemia, received 2026-09-16, accepted 2026-10-21); the slowest took 308 days. The average is 126.8 days and the median is 114 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
